A sample number of beneficiaries will undergo a mock immunisation process. Staff of vaccination centres, a select group of healthcare workers will participate in the mock immunisation drive
Experts at India's drugs regulator have recommended two coronavirus vaccines for emergency use, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute.
Virus Outbreak: India holds nationwide vaccine drills
AFP, NEW DELHI
India yesterday staged nationwide drills to start one of the world’s biggest COVID-17 vaccination programs as the drug regulator prepared to approve the first vaccine.
An Indian government panel on Friday recommended emergency use of the AstraZeneca-Oxford University shot and the first injections could be given in the coming week after the Drugs Control Authority of India gives final approval.
India, which has more than 10.2 million infection cases has set a target of inoculating 300 million of its 1.3 billion people by the middle of this year.
Serum Institute of India, the world’s biggest vaccine producer, has already stockpiled tens of millions of doses of AstraZeneca’s Covishield ready for the campaign and 96,000 health workers have been trained for the inoculation drive.
India approves AstraZeneca Covid vaccine, stages nationwide drill
Issued on:
02/01/2021 - 08:27 India is staging a test run before starting one of the world s biggest coronavirus vaccination programmes Noah SEELAM AFP 3 min India has staged nationwide drills to start one of the world s biggest coronavirus vaccination programmes as the drug regulator approved the country s first vaccine, AstraZeneca s Covishield. Advertising
New Delhi (AFP)
A government panel on Friday recommended emergency use of the AstraZeneca-Oxford University shot and the first injections could be given in the coming week after the Drugs Control Authority of India gives its final approval.
India, which has the world s second highest number of pandemic cases more than 10.2 million has set an ambitious target of inoculating 300 million of its 1.3 billion people by mid-2021.